NCT06002009 SupraScapular Cuff Study: Assessing the Effects of Size and Type of Rotator Cuff Tear on Suprascapular Nerve Function
| NCT ID | NCT06002009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospitals of North Midlands NHS Trust |
| Condition | Orthopedic Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-06-23 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-06-23 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the study is to determine in adult patients with a rotator cuff tear, what size and pattern of rotator cuff tear would result in damage to the suprascapular nerve. The secondary objectives are 1. To determine if an injured suprascapular nerve can recover if the rotator cuff tear is surgically repaired. 2. To determine if there is a limit of retraction before the suprascapular nerve is irreversibly damaged. 3. To determine factors that are protective against SSN injury. 4. Can the patient data gathered be used to optimise operative procedures.
Eligibility Criteria
Inclusion Criteria: • All patients age ≥18 years presenting to a UHNM shoulder clinic with a confirmed diagnosis of a rotator cuff tear (affecting one or both shoulders). Exclusion Criteria: * Bony pathology (such as significant shoulder arthritis that would exclude isolated rotator cuff repair) * Grossly abnormal shoulder anatomy * Motor Neurone Disease * Cervical cord disease affecting the SSN nerve roots * Patients unable to undergo MRI scan * Previous surgery at the affected glenohumeral joint * Patients unable to tolerate NCS * Acute fracture affecting the glenohumeral joint * Recent glenohumeral joint dislocation (past 12 months) * Patients unable or unwilling to give full informed consent * Patients unable or unwilling to comply with the study procedures
Contact & Investigator
Damian McClelland
PRINCIPAL INVESTIGATOR
University Hospital of North Midlands NHS Trust
Frequently Asked Questions
Who can join the NCT06002009 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Orthopedic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06002009 currently recruiting?
Yes, NCT06002009 is actively recruiting participants. Contact the research team at megan.young@uhnm.nhs.uk for enrollment information.
Where is the NCT06002009 trial being conducted?
This trial is being conducted at Stoke-on-Trent, United Kingdom.
Who is sponsoring the NCT06002009 clinical trial?
NCT06002009 is sponsored by University Hospitals of North Midlands NHS Trust. The principal investigator is Damian McClelland at University Hospital of North Midlands NHS Trust. The trial plans to enroll 250 participants.